The human studies that do exist are typically small (often fewer than 100 participants), short in duration (commonly eight to twelve weeks), and methodologically inconsistent, with significant heterogeneity in dosing, formulation, and outcome measures
In parallel, addressing any nutritional gaps through food-first strategies and, where appropriate, supplements can improve the hairs building blocks
VESPER-3 VESPER-3 was a 64-week placebo-controlled trial that assessed the efficacy and safety of monthly berobenatide in adults with obesity or overweight with hypertension and/or dyslipidemia
Your Semaglutide dosage is carefully calibrated and adjusted based on your response and tolerance
Ast J, Arvaniti A, Fine NHF, Nasteska D, Ashford FB, Stamataki Z, et al
If you haven't lost any weight or seen appetite changes by week 10 at a full dose, discuss next steps with your provider or consider genetic testing through PlexusDx